Arcadia Biosciences Inc
RKDA
Get informed when a big investor buys or sells
+ FollowMarket Cap$445.94K
Close$
$5.03
1645.4% upside
Current Fair Value
1645.4% upsideUndervalued by 1645.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $445,937.00 |
|---|---|
| Enterprise Value | $-3,732,063.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.71 |
| Beta | 0.53 |
| Outstanding Shares | 1,368,057 |
Return
| Return on Equity | -1758.45% |
|---|---|
| Return on Assets | -188.89% |
| Return on Invested Capital | 93.62% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.09 |
| Price to Sales | 0.1 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.79 |
| Enterprise Value to EBIT | -0.94 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$2.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.46%▼ 10.08% |
|---|---|
| Total Invested | $145,768▼ 69.77% |
| Investors Holding | 16▲ 1.00% |
ESG Score
No data